Colchicine in the treatment of pulmonary fibrosis

Chest

Volumn 103, Issue 1, 1993, Pages 101-104

  Peters, S G ^a   McDougall, J C ^a   Douglas, W W ^a   Coles, D T ^a   DeRemee, R A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; COLLAGEN; CYCLOPHOSPHAMIDE; FIBROBLAST GROWTH FACTOR; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; DRUG TOLERANCE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG BIOPSY; LUNG FIBROSIS; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0027459992     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.103.1.101     Document Type: Article

References (24)

1. RA DeRemee EG Harrison HA Andersen The concept of classic interstitial pneumonitis-fibrosis (CIF-F) as a clinicopathologic syndrome Chest 61 1972 213 220
2. CB Carrington EA Gaensler RE Coutu MX Fitzgerald RG Gupta Natural history and treated course of usual and desquamative interstitial pneumonia N Engl J Med 298 1978 801 809
3. RG Crystal JE Gadek WI Ferrans JD Fulmer BR Line GW Hunninghake Interstitial lung disease: current concepts of pathogenesis, staging, and therapy Am J Med 70 1981 542 568
4. RM Cherniack RG Crystal AR Kalica Current concepts in idiopathic pulmonary fibrosis: a road map for the future Am Rev Respir Dis 143 1991 680 683
5. M Turner-Warwick B Burrows A. Johnson Cryptogenic fibrosing alveolitis: clinical features and their influence on survival Thorax 35 1980 171 180
6. CP Wall EA Gaensler CG Carrington JA Hayes Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases Am Rev Respir Dis 123 1981 280 285
7. RP Daniele JA Elias PE Epstein MD Rossman Bronchoalveolar lavage: role in the pathogenesis, diagnosis and management of interstitial lung disease Ann Intern Med 102 1985 93 108
8. RM Rudd PL Haslam M. Turner-Warwick Cryptogenic fibrosing alveolitis: relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis Am Rev Respir Dis 124 1981 1 8
9. M Turner-Warwick B Burrows A. Johnson Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival Thorax 35 1980 593 599
10. BA Keough J Bernards GW Hunninghake BR Line DL Price RG Crystal Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis Am Rev Respir Dis 127 1983 18 22
11. RH Winterbauer SP Hammar KO Hallman JE Hays NE Pardee EH Morgan Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisone/azathioprine Am J Med 65 1978 661 672
12. G Raghu WJ Depaso K Cain SP Hammar CE Wetzel DF Dreis Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled trial Am Rev Respir Dis 144 1991 291 296
13. J Weiland P Dorinsky WB Davis E Pacht D Thomson J. Gadek Use of cyclophosphamide in the therapy of idiopathic pulmonary fibrosis Chest 89 1986 150S 151S
14. MA Johnson S Kwan NJ Snell AJ Nunn JH Darbyshire M. Turner-Warwick Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis Thorax 44 1989 280 288
15. RH Winterbauer The treatment of idiopathic pulmonary fibrosis Chest 100 1991 233 235
16. U Costabel H. Matthys Different therapies and factors influencing response to therapy in idiopathic difluse fibrosing alveolitis Respiration 42 1981 141 149
17. UH Cegla Treatment of idiopathic fibrosing alveolitis: therapeutic experiences with azathioprine-prednisolone and D-penicillamine-prednisolone combination therapy Schweiz Med Wochenschr 107 1977 184 187
18. J Meier-Sydow M Rust H Kronenberger C Thiel M Amthor H. Riemann Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprine or D-penicillamine Prax Pneumol 33 1979 680 688
19. RJ Flower S Moncada JR Vane Drug therapy of inflammation Gilman AG Goodman LS Rall TW Murad F Goodman and Gilman's the pharmacological basis of therapeutics 1985 Macmillan New York
20. SI Rennard PB Bitterman T Ozaki WN Rom RG Crystal Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro: the basis of a possible therapeutic approach to the fibrotic disorders Am Rev Respir Dis 137 1988 181 185
21. D Kershenobich F Vargas G Garcia-Tsao R Perez Temayo M Gent M. Rojkind Colchicine in the treatment of cirrhosis of the liver N Engl J Med 318 1988 1709 1713
22. AB Cohen W Girard J McParty B Starcher D Davis M Stevens A controlled trial of colchicine to reduce the elastase load in the lungs of ex-cigarette smokers with chronic obstructive pulmonary disease Am Rev Respir Dis 143 1991 1038 1043
23. RA DeRemee Specific entities Clinical profiles of difluse interstitial pulmonary disease 1990 Futura Publishing Co New York 151 152
24. SG Peters JR Jett JH Ryu PL Enright Reproducibility of pulmonary function tests in patients with idiopathic pulmonary fibrosis Chest 96 1989 206S